Phenotypic features of epilepsy due to sodium channelopathies – A single center experience from India

Objectives: Nearly 40% of pediatric epilepsies have a genetic basis. There is significant phenotypic and genotypic heterogeneity, especially in epilepsy syndromes caused by sodium channelopathies. Sodium channel subunit 1A (SCN1A)-related epilepsy represents the archetypical channel-associated gene that has been linked to a wide spectrum of epilepsies of varying severity. Subsequently, other sodium channels have also been implicated in epilepsy and other neurodevelopmental disorders. This study aims to describe the phenotypes in children with sodium channelopathies from a center in Southern India. Materials and Methods: This is a retrospective, descriptive, and single-center study. Out of 112 children presenting with epilepsy who underwent genetic testing between 2017 and 2021, 23 probands (M: F = 12:11) were identified to have clinically significant sodium channel mutations. Clinical presentation, electroencephalography, and imaging features of these patients were recorded. The utility of genetic test results (e.g., in planning another child, withdrawal of medications, or change in treatment) was also recorded. Results: Age at onset of seizures ranged from day 4 of life to 3.5 years. Clinical epilepsy syndromes included generalized epilepsy with febrile seizures plus ( n = 3), Dravet syndrome ( n = 5), early infantile epileptic encephalopathy ( n = 7), drug-resistant epilepsy ( n = 5), and epilepsy with associated movement disorders ( n = 3). The most common type of seizure was focal with impaired awareness ( n = 18, 78.2%), followed by myoclonic jerks ( n = 8, 34.78%), epileptic spasms ( n = 7, 30.4%), bilateral tonic-clonic seizures/generalized tonic–clonic seizures ( n = 3, 13%), and atonic seizures ( n = 5, 23.8%). In addition to epilepsy, other phenotypic features that were discerned were microcephaly ( n = 1), cerebellar ataxia ( n = 2), and chorea and dystonia ( n = 1). Conclusion: Sodium channelopathies may present with seizure phenotypes that vary in severity. In addition to epilepsy, patients may also have other clinical features such as movement disorders. Early clinical diagnosis may aid in tailoring treatment for the given patient.